Registration Dossier

Administrative data

Endpoint:
basic toxicokinetics, other
Type of information:
other: expert statement
Adequacy of study:
key study
Study period:
2021
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
study well documented, meets generally accepted scientific principles, acceptable for assessment

Data source

Reference
Title:
Unnamed
Year:
2021
Report date:
2021

Materials and methods

Objective of study:
toxicokinetics
Test guideline
Qualifier:
according to guideline
Guideline:
other: according to ECHA Guidance R.7c, June 2017, v.3

Test material

Constituent 1
Chemical structure
Reference substance name:
Disodium 4-amino-3-[[4-[(2,4-diaminophenyl)azo]phenyl]azo]-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulphonate
EC Number:
272-559-0
EC Name:
Disodium 4-amino-3-[[4-[(2,4-diaminophenyl)azo]phenyl]azo]-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulphonate
Cas Number:
68877-33-8
Molecular formula:
C28H21N9O7S2.2Na
IUPAC Name:
Disodium 4-amino-3-[[4-[(2,4-diaminophenyl)azo]phenyl]azo]-5- hydroxy-6-(phenylazo)naphthalene-2,7-disulphonate

Results and discussion

Main ADME results
Type:
absorption
Results:
estimated for risk assessement purposes: oral 50%; dermal 50%; inhalation 50%

Applicant's summary and conclusion

Conclusions:
Based on the available data and according to a qualitative assessment according to ECHA Guidance R.7c, June 2017, v.3, the substance has not a bioaccumulation potential.